Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy

Abstract Background Epilepsy is a major symptom in patients with glioma. Levetiracetam (LEV) is recognized as a first-line treatment for glioma-related epilepsy. Increasing the LEV dose is allowed into patients with seizure occurrence against its initial dose. However, the therapeutic efficacy of in...

Descrición completa

Detalles Bibliográficos

Principais autores:	Etsuko Yamamoto Hattori, Yoshiki Arakawa, Yohei Mineharu, Keiko Furukawa, Yukinori Terada, Yukihiro Yamao, Masahiro Tanji, Takayuki Kikuchi, Susumu Miyamoto
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2023-09-01
Series:	BMC Cancer
Assuntos:	Antiseizure medication Levetiracetam Glioma-related epilepsy Seizure occurrence Increasing dose
Acceso en liña:	https://doi.org/10.1186/s12885-023-11273-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!